Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas
FRIEDBERG, Jonathan W, MAHADEVAN, Daruka, FINGERT, Howard, DANAEE, Hadi, BERNSTEIN, Steven H, CEBULA, Erin, PERSKY, Daniel, LOSSOS, Izidore, AGARWAL, Amit B, JUNGAH JUNG, BURACK, Richard, XIAOFEI ZHOU, LEONARD, E. Jane
Published in Journal of clinical oncology (01.01.2014)
Published in Journal of clinical oncology (01.01.2014)
Get full text
Journal Article
Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas
Holkova, Beata, Kmieciak, Maciej, Bose, Prithviraj, Yazbeck, Victor Y, Barr, Paul M, Tombes, Mary Beth, Shrader, Ellen, Weir-Wiggins, Caryn, Rollins, April D, Cebula, Erin M, Pierce, Emily, Herr, Megan, Sankala, Heidi, Hogan, Kevin T, Wan, Wen, Feng, Changyong, Peterson, Derick R, Fisher, Richard I, Grant, Steven, Friedberg, Jonathan W
Published in Leukemia & lymphoma (03.03.2016)
Published in Leukemia & lymphoma (03.03.2016)
Get full text
Journal Article
Phase I Trial Of Carfilzomib In Combination With Vorinostat (SAHA) In Patients With Relapsed/Refractory B-Cell Lymphomas
Holkova, Beata, Kmieciak, Maciej, Bose, Prithviraj, Barr, Paul M., Tombes, Mary Beth, Shrader, Ellen, Cebula, Erin, Pierce, Emily, Herr, Megan M., Sankala, Heidi, Feng, Changyong, Fisher, Richard I, Grant, Steven, Friedberg, Jonathan W.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Redox Associated Gene Expression Predicts For Responses To The Pro-Oxidant Molecule Imexon In Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma: Results Of a Multi-Center Phase II Study
Barr, Paul M., Briehl, Margaret M., Bernstein, Steven H, Friedberg, Jonathan W., Baran, Andrea, Peterson, Derick R., Persky, Daniel Oscar, Casulo, Carla, Herr, Megan M., Littleton, Jamie, Cebula, Erin, Schwartz, Mark, Puvvada, Soham D., Dorr, Robert T, Fisher, Richard I, Miller, Thomas P.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Effect of Prior Rituximab on Residence Time of I131 Tositumomab Consolidation Therapy in Patients (pts) with Non Hodgkin's Lymphoma (NHL): Analysis of SWOG Clinical Trials
Schaefer-Cutillo, Julia, Chengazi, Vaseem, Peterson, Derick R, Maloney, David G., Kibler, Kevin, Cebula, Erin, Bernstein, Steven, Young, Faith, Press, Oliver W., Rimsza, Lisa M., Fisher, Richard I., Friedberg, Jonathan W.
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas
Holkova, Beata, Kmieciak, Maciej, Bose, Prithviraj, Yazbeck, Victor Y., Barr, Paul M., Tombes, Mary Beth, Shrader, Ellen, Weir-Wiggins, Caryn, Rollins, April D., Cebula, Erin M., Pierce, Emily, Herr, Megan, Sankala, Heidi, Hogan, Kevin T., Wan, Wen, Feng, Changyong, Peterson, Derick R., Fisher, Richard I., Grant, Steven, Friedberg, Jonathan W.
Published in Leukemia & Lymphoma (03.03.2016)
Published in Leukemia & Lymphoma (03.03.2016)
Get full text
Report